CooperSurgical Inc.

Company Snapshot

Founded: 1990
Entity Type: Private
Region: U.S.
Headquarter: U.S.
Key Geographics: North America, Europe, Asia-Pacific, Middle-East
Corporate Address: 75 Corporate Drive Trumbull Connecticut 06611 U.S. Tel. +1-203-601-5200 www.coopersurgical.com

Company Overview

CooperSurgical Inc. is focused on manufacturing and marketing medical devices and procedure solutions for healthcare professionals and institutions providing care to and for women. The company’s portfolio includes cryotherapy, a time-tested therapy for treating various medical conditions, as well as an array of products, including wide-seal silicone diaphragm kits, surgical solutions, and fertility assessment products for family planning needs ranging from contraception to insemination.

CooperSurgical also provides diagnostic disposables, such as endometrial samplers, cervical and endocervical samplers, uterine infusion catheters, skin punches, and breast aspirators; examination instruments that include biopsy punches, curettes, dilators and sounds, endometrial samplers, Keyes punches, specula, and vaginal wall retractors, as well as forceps, tenacula, and hooks; and patient education programs.

Additionally, CooperSurgical offers digital colposcopy systems and sexual assault documentation systems; colposcopy instruments; LEEP system and smoke–evacuators, instruments, and accessories; cryosurgery products; incontinence and pelvic floor devices to diagnose the cause of female incontinence; and surgical products for laparoscopic and open surgical procedures. CooperSurgical was established in 1990 and is based in Trumbull, Conn. CooperSurgical Inc. operates as a subsidiary of Cooper Medical Inc. 

CooperSurgical Inc. In Reports

Fetal Monitoring, Diagnostics and Predictive Tests

BCC Research Market Report says fetal monitoring diagnostics and predictive tests is estimated to increase from $10.4 bln in 2022 to reach $13.6 bln by 2027 at a CAGR of 5.6%

Human Reproductive Technologies: Products and Global Markets

BCC Research Market Analysis Report Says human reproductive technologies and products is valued at $16.1 bln in 2021 and is estimated to grow from $17.1 bln in 2022 to $24 bln in 2027.

Global DNA Sequencing: Research, Applied and Clinical Markets

BCC Research Market Report for DNA Sequencing Industry. Global market for DNA sequencing technologies and their applications in research, applied and clinical segments.

Applications/End User Industries

  • Healthcare